Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,138.80
(
-0.49%
)
US TECH 100
26,370.00
(
-0.75%
)
Dow Jones
49,141.93
(
-0.34%
)
Brent Oil
103.82
(
-0.57%
)
Bitcoin
76,326.76
(
-0.02%
)
News Focus
News Focus
Post# of 823423
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

doubleb73

Send PM Follow Ignore
Followers 1
Posts 36
Boards Moderated 0
Alias Born 10/29/2014

doubleb73

Re: sentiment_stocks post# 243582

Tuesday, 09/10/2019 7:39:13 PM

Tuesday, September 10, 2019 7:39:13 PM

Post# of 823423
Its called desperation. Just like BMY buying Celgene. These large pharma get pressured by their sinking stock price to make acquisitions that are over priced that don’t create shareholder returns most of the time.

CAR-T have long expensive roads ahead paved with toxicity risk.

Eventually a dendritic cell vaccine will be what they are chasing to partner with in new trials.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News